Form 4: Salesforce CFO Amy Weaver Reports Stock Transactions
SEC Form 4 Filing
Amy Weaver, President and CFO of Salesforce, executed stock transactions on March 3, 2025, including option exercises and stock sales, according to a Form 4 filing.
Summary
- Amy Weaver, the President and CFO of Salesforce, filed a Form 4 detailing changes in beneficial ownership of Salesforce stock.
- On March 3, 2025, Weaver exercised non-qualified stock options to acquire 2,198 shares at $215.17 and 4,023 shares at $218.21.
- Also on March 3, 2025, Weaver sold 6,221 shares of common stock at $301.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 24, 2024.
- Following these transactions, Weaver directly owns 46,750 shares of Salesforce common stock and holds options for 45,655 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.
Industry Context
Executive stock transactions are common and closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are a standard tool for executives to manage their stock transactions while avoiding insider trading concerns.
Comparison to Industry Standards
- Executive compensation packages in the tech industry often include stock options as a significant component.
- The vesting schedules and exercise prices of these options are generally aligned with industry norms to incentivize long-term performance.
- Salesforce's executive compensation practices are likely benchmarked against those of its peers, such as Microsoft, Oracle, and SAP.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders if it signals a change in executive sentiment, but the existence of a 10b5-1 plan mitigates this concern.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/22/2022 | First vesting date for 25% of the 2,198 options granted. |
| 03/22/2023 | First vesting date for 25% of the 4,023 options granted. |
| 09/24/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 03/03/2025 | Date of stock option exercises and stock sale. |
| 03/04/2025 | Date of Form 4 filing. |
| 03/22/2028 | Expiration date of the 2,198 options. |
| 03/22/2029 | Expiration date of the 4,023 options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.